|
| 37406366 | Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases. | Int J Gynecol Pathol | 2024 |
| 37752678 | Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study. | BJOG | 2024 |
| 36368129 | Profiling the immune landscape in mucinous ovarian carcinoma. | Gynecol Oncol | 2023 |
| 37657461 | Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial. | Lancet Oncol | 2023 |
| 38057616 | Deep learning-based segmentation of multisite disease in ovarian cancer. | Eur Radiol Exp | 2023 |
| 37843101 | Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials. | Health Technol Assess | 2023 |
| 37980767 | Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Gynecol Oncol | 2023 |
| 37875466 | Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer. | Nat Commun | 2023 |
| 37500307 | Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance. | Pathology | 2023 |
| 37773079 | Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas. | Clin Cancer Res | 2023 |
| 37494476 | Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer. | Cancer Res | 2023 |
| 37191121 | Commentary: novel observations and detailed molecular characterisation of mixed tumours and mesonephric-like carcinosarcomas by Mirkovic et al. (2023). | Histopathology | 2023 |
| 37423805 | To the editor. | Gynecol Oncol | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 37183782 | Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial. | Health Technol Assess | 2023 |
| 37244485 | Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes. | Transl Res | 2023 |
| 36788074 | Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories. | Mod Pathol | 2023 |
| 36853794 | Reply to Comment on HPV-independent, p53-Wild-type Vulvar Intraepithelial Neoplasia: A Review of Nomenclature and the Journey to Characterize Acanthotic Precursor Lesions of the Vulva. | Mod Pathol | 2023 |
| 36740684 | A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors. | Diagn Pathol | 2023 |
| 36739268 | The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype. | Gynecol Oncol | 2023 |
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36496303 | Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts. | Lancet Digit Health | 2023 |
| 36731023 | Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol. | Int J Gynecol Pathol | 2023 |
| 34555263 | Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS. | BJOG | 2022 |
| 35703457 | Data Set for the Reporting of Carcinomas of the Vagina: Recommendations From the International Collaboration on Cancer Reporting (ICCR). | Int J Gynecol Pathol | 2022 |
| 35437330 | HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva. | Mod Pathol | 2022 |
| 35764349 | Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique. | Int J Gynecol Cancer | 2022 |
| 35398881 | The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma. | Clin Cancer Res | 2022 |
| 35464500 | A Case Report of the Largest Submucosal Uterine Leiomyoma Removed by Single-Session Hysteroscopic Myomectomy in the Caribbean. | Cureus | 2022 |
| 35785153 | Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma. | Front Oncol | 2022 |
| 35554675 | The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance. | Virchows Arch | 2022 |
| 36305532 | Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR). | Int J Gynecol Pathol | 2022 |
| 36065012 | Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images. | Mod Pathol | 2022 |
| 33720084 | Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies. | Int J Gynecol Pathol | 2022 |
| 33664191 | Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive Reporting. | Int J Gynecol Pathol | 2022 |
| 34996131 | Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). | Histopathology | 2022 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 32980858 | Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871-879. | Mod Pathol | 2021 |
| 33687171 | The ISGyP Endocervical Adenocarcinoma Project: Master Plan Summary, Acknowledgment of Participants, and Participant Responses to Final Recommendations of the Expert Panels. | Int J Gynecol Pathol | 2021 |
| 33687170 | Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists. | Int J Gynecol Pathol | 2021 |
| 33494753 | Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar. | Trials | 2021 |
| 33570866 | Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists. | Int J Gynecol Pathol | 2021 |
| 33570864 | Grading of Endocervical Adenocarcinomas: Review of the Literature and Recommendations From the International Society of Gynecological Pathologists. | Int J Gynecol Pathol | 2021 |
| 33570861 | Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance. | Int J Gynecol Pathol | 2021 |
| 33648562 | UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis. | Trials | 2021 |
| 33706757 | Primary mucinous ovarian tumors vs. ovarian metastases from gastrointestinal tract, pancreas and biliary tree: a review of current problematics. | Diagn Pathol | 2021 |
| 33671249 | How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature. | Cancers (Basel) | 2021 |
| 33670571 | Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). | Cancers (Basel) | 2021 |
| 33835523 | Performance of a HER2 testing algorithm specific for p53-abnormal endometrial cancer. | Histopathology | 2021 |
| 33551198 | Corrigendum to "Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data" Gynecol. Oncol. 154 (2019) 441-448. | Gynecol Oncol | 2021 |